Spyre Therapeutics
SYRE
SYRE
103 hedge funds and large institutions have $1.21B invested in Spyre Therapeutics in 2024 Q1 according to their latest regulatory filings, with 55 funds opening new positions, 20 increasing their positions, 15 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
103
Holders Change
+49
Holders Change %
+90.74%
% of All Funds
1.49%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.07%
New
55
Increased
20
Reduced
15
Closed
6
Calls
$76K
Puts
–
Net Calls
+$76K
Net Calls Change
+$32K
Top Buyers
1 |
![]()
Fidelity Investments
Boston,
Massachusetts
|
+$105M |
2 |
BlackRock
New York
|
+$20.4M |
3 |
DGM
Darwin Global Management
St. Helier,
Jersey
|
+$17.9M |
4 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$17.7M |
5 |
FTM
First Turn Management
Del Mar,
California
|
+$17.6M |